Depolabo Report issue

For profit Phase 4
Founded: Marseilles France (1957)
Status: Acquired by The Boots Company (2008) → now IG Farben (1925)

Organization Overview

First Clinical Trial
2008
NCT00768053
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2008

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Active Ingredients

Drugs in Phase 4 Trials (1)

etanercept (enbrel) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Arthritis (Phase 4)

Arthritis, Rheumatoid (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 1
  • # of Trial APIs: 1